Search details
1.
Lactiplantibacillus plantarum: a new example of inclusion body producing bacteria.
Microb Cell Fact
; 22(1): 111, 2023 Jun 09.
Article
in English
| MEDLINE | ID: mdl-37296442
2.
The High Plasticity of Nonpathogenic Mycobacterium brumae Induces Rapid Changes in Its Lipid Profile during Pellicle Maturation: The Potential of This Bacterium as a Versatile Cell Factory for Lipid Compounds of Therapeutic Interest.
Int J Mol Sci
; 23(21)2022 Nov 06.
Article
in English
| MEDLINE | ID: mdl-36362396
3.
Engineering Protein Nanoparticles Out from Components of the Human Microbiome.
Small
; 16(30): e2001885, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32578402
4.
Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications.
Microb Cell Fact
; 19(1): 175, 2020 Sep 04.
Article
in English
| MEDLINE | ID: mdl-32887587
5.
Recruiting potent membrane penetrability in tumor cell-targeted protein-only nanoparticles.
Nanotechnology
; 30(11): 115101, 2019 Mar 15.
Article
in English
| MEDLINE | ID: mdl-30561375
6.
Selective CXCR4+ Cancer Cell Targeting and Potent Antineoplastic Effect by a Nanostructured Version of Recombinant Ricin.
Small
; 14(26): e1800665, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29845742
7.
Conformational Conversion during Controlled Oligomerization into Nonamylogenic Protein Nanoparticles.
Biomacromolecules
; 19(9): 3788-3797, 2018 09 10.
Article
in English
| MEDLINE | ID: mdl-30052033
8.
Switching cell penetrating and CXCR4-binding activities of nanoscale-organized arginine-rich peptides.
Nanomedicine
; 14(6): 1777-1786, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29777875
9.
Engineering multifunctional protein nanoparticles by in vitro disassembling and reassembling of heterologous building blocks.
Nanotechnology
; 28(50): 505102, 2017 Dec 15.
Article
in English
| MEDLINE | ID: mdl-29072576
10.
A combination of lactic acid bacteria regulates Escherichia coli infection and inflammation of the bovine endometrium.
J Dairy Sci
; 100(1): 479-492, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-27837977
11.
Cellular uptake and intracellular fate of protein releasing bacterial amyloids in mammalian cells.
Soft Matter
; 12(14): 3451-60, 2016 Apr 14.
Article
in English
| MEDLINE | ID: mdl-26956912
12.
Functional inclusion bodies produced in the yeast Pichia pastoris.
Microb Cell Fact
; 15(1): 166, 2016 Oct 01.
Article
in English
| MEDLINE | ID: mdl-27716225
13.
Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.
Microb Cell Fact
; 15: 59, 2016 Apr 08.
Article
in English
| MEDLINE | ID: mdl-27059706
14.
Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles.
Nanomedicine
; 12(5): 1241-51, 2016 07.
Article
in English
| MEDLINE | ID: mdl-26949165
15.
High-precision targeting and destruction of cancer-associated PDGFR-ß+ stromal fibroblasts through self-assembling, protein-only nanoparticles.
Acta Biomater
; 170: 543-555, 2023 Oct 15.
Article
in English
| MEDLINE | ID: mdl-37683965
16.
Cyclopropanation of α-mycolic acids is not required for cording in Mycobacterium brumae and Mycobacterium fallax.
Microbiology (Reading)
; 158(Pt 6): 1615-1621, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22493302
17.
Differential interactions of virulent and non-virulent H. parasuis strains with naïve or swine influenza virus pre-infected dendritic cells.
Vet Res
; 43: 80, 2012 Nov 16.
Article
in English
| MEDLINE | ID: mdl-23157617
18.
Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery.
J Control Release
; 343: 277-287, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35051493
19.
Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials.
Pharmaceutics
; 14(1)2022 Jan 14.
Article
in English
| MEDLINE | ID: mdl-35057088
20.
Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-γ/IL-17 release in bladder cancer treatment.
Oncoimmunology
; 11(1): 2051845, 2022.
Article
in English
| MEDLINE | ID: mdl-35355681